( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57



Sombel Mazhar*, Roma Ehsan and Mariam Zaka


Background: Diabetes mellitus (DM) is a prevalent disorder worldwide, characterized by elevated serum glucose levels and a constellation of symptoms including polydipsia, polyuria and fluctuations in weight. The mainstay of treatment for DM depends greatly on the A1C levels. A1C levels measure the average blood glucose level over the past two to three months. In order to prevent progression of DM patients are treated with lifestyle modifications and a combination of pharmacological agents to achieve long term glycemic control. One such combination includes Metformin and an oral antihyperglycemic agent such as Sulfonylureas. This combination of medications will be the focus of this study on patients with Type 2 Diabetes (T2DM). Objective: The objective of this study is to evaluate the effectiveness of a combination of sulfonylurea and metformin on glycemic control in patients with Type 2 Diabetes Mellitus. Methods: A cross-sectional study design was adopted using a convenient sampling technique during a one month period from June to August, 2017. A sample size of 100 patients was studied and data was collected from two major hospitals in Lahore, Pakistan. A data collection form was designed and was filled during face to face interviews with the patients, and physicians. Data was presented as a percentage. Results: The study showed that 80% of the patients were prescribed metformin, 20% sulfonylureas. 90% patients have performed their HbA1c. Conclusion: Type II diabetes is a common disease prevailing throughout the world. Type II diabetes is also associated with several other metabolic abnormalities. The main pathologic defects in diabetes consist of excessive hepatic glucose production, peripheral insulin resistance and defective beta-cell secretory function. Metformin improves glycemic control by reducing hepatic glucose production, increasing insulin sensitivity, and reducing intestinal glucose absorption, without increasing insulin secretion. Sulfonylureas prefer for metabolic abnormalities by reducing hypoglycemia.

Keywords: Type 2 Diabetes Mellitus, treatment, Oral antibiotic agents, Older people.

[Full Text Article]




    AUGUST Issue has been successfully launched on 1 August 2022.

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 August 2022 Issue has been Published, Kindly check it on

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database